Boris A. Reva

MutationAssessor version 4 provides updated functional impact scores for mutations using expanded data and improved analysis methods, now integrated into cBioPortal.

The paper analyzes CPTAC phosphoproteomics data to identify kinase activity differences between tumor and normal tissues across cancers and develops a web portal for querying kinase activity scores and associated data.

This study ranks prostate cancer tumors along the IFN-γ/PD-L1 axis to prioritize patients for immune checkpoint therapy and identifies immune resistance mechanisms.

ProTrack provides an interactive web tool for exploring CPTAC proteogenomic data across multiple cancer types, enabling users to query and visualize multi-omics profiles without coding.